Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock financial statements, including revenue, expenses, profit, and loss

The total revenue of CYCCP for the last quarter is 29.00 k USD, and it's 6.45% lower compared to the previous quarter. The net income of Q1 24 is -2.95 M USD.